202 related articles for article (PubMed ID: 17885291)
1. The presence of the Trim5alpha escape mutation H87Q in the capsid of late stage HIV-1 variants is preceded by a prolonged asymptomatic infection phase.
Kootstra NA; Navis M; Beugeling C; van Dort KA; Schuitemaker H
AIDS; 2007 Oct; 21(15):2015-23. PubMed ID: 17885291
[TBL] [Abstract][Full Text] [Related]
2. Naturally Occurring Mutations in HIV-1 CRF01_AE Capsid Affect Viral Sensitivity to Restriction Factors.
Nakayama EE; Saito A; Sultana T; Jin Z; Nohata K; Shibata M; Hosoi M; Motomura K; Shioda T; Sangkitporn S; Loket R; Saeng-Aroon S
AIDS Res Hum Retroviruses; 2018 Apr; 34(4):382-392. PubMed ID: 29325426
[TBL] [Abstract][Full Text] [Related]
3. The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.
van Manen D; Rits MA; Beugeling C; van Dort K; Schuitemaker H; Kootstra NA
PLoS Pathog; 2008 Feb; 4(2):e18. PubMed ID: 18248091
[TBL] [Abstract][Full Text] [Related]
4. The Three-Fold Axis of the HIV-1 Capsid Lattice Is the Species-Specific Binding Interface for TRIM5α.
Morger D; Zosel F; Bühlmann M; Züger S; Mittelviefhaus M; Schuler B; Luban J; Grütter MG
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237846
[TBL] [Abstract][Full Text] [Related]
5. Adaptation of HIV-1 to cells expressing rhesus monkey TRIM5α.
Pacheco B; Finzi A; Stremlau M; Sodroski J
Virology; 2010 Dec; 408(2):204-12. PubMed ID: 20956011
[TBL] [Abstract][Full Text] [Related]
6. Delaying reverse transcription does not increase sensitivity of HIV-1 to human TRIM5α.
Battivelli E; Lecossier D; Clavel F; Hance AJ
PLoS One; 2013; 8(1):e52434. PubMed ID: 23320071
[TBL] [Abstract][Full Text] [Related]
7. The V86M mutation in HIV-1 capsid confers resistance to TRIM5α by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import.
Veillette M; Bichel K; Pawlica P; Freund SM; Plourde MB; Pham QT; Reyes-Moreno C; James LC; Berthoux L
Retrovirology; 2013 Feb; 10():25. PubMed ID: 23448277
[TBL] [Abstract][Full Text] [Related]
8. Role of TRIM5α RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virus.
Kim J; Tipper C; Sodroski J
J Virol; 2011 Aug; 85(16):8116-32. PubMed ID: 21680520
[TBL] [Abstract][Full Text] [Related]
9. TRIM5α Resistance Escape Mutations in the Capsid Are Transferable between Simian Immunodeficiency Virus Strains.
Wu F; Kirmaier A; White E; Ourmanov I; Whitted S; Matsuda K; Riddick N; Hall LR; Morgan JS; Plishka RJ; Buckler-White A; Johnson WE; Hirsch VM
J Virol; 2016 Dec; 90(24):11087-11095. PubMed ID: 27681142
[TBL] [Abstract][Full Text] [Related]
10. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection.
Li Y; Li X; Stremlau M; Lee M; Sodroski J
J Virol; 2006 Jul; 80(14):6738-44. PubMed ID: 16809279
[TBL] [Abstract][Full Text] [Related]
11. Retroviral restriction factors TRIM5α: therapeutic strategy to inhibit HIV-1 replication.
Zhang J; Ge W; Zhan P; De Clercq E; Liu X
Curr Med Chem; 2011; 18(17):2649-54. PubMed ID: 21568899
[TBL] [Abstract][Full Text] [Related]
12. Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection.
Speelmon EC; Livingston-Rosanoff D; Li SS; Vu Q; Bui J; Geraghty DE; Zhao LP; McElrath MJ
J Virol; 2006 Mar; 80(5):2463-71. PubMed ID: 16474153
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific restriction of cyclophilin A-independent HIV-1- and SIV-derived lentiviral vectors.
Kahl CA; Cannon PM; Oldenburg J; Tarantal AF; Kohn DB
Gene Ther; 2008 Aug; 15(15):1079-89. PubMed ID: 18385767
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Assessment of Mutant Human TRIM5α as an Anti-HIV-1 Transgene.
Jung U; Urak K; Veillette M; Nepveu-Traversy MÉ; Pham QT; Hamel S; Rossi JJ; Berthoux L
Hum Gene Ther; 2015 Oct; 26(10):664-79. PubMed ID: 26076730
[TBL] [Abstract][Full Text] [Related]
15. Homology-based identification of capsid determinants that protect HIV1 from human TRIM5α restriction.
Maillard PV; Zoete V; Michielin O; Trono D
J Biol Chem; 2011 Mar; 286(10):8128-8140. PubMed ID: 21169362
[TBL] [Abstract][Full Text] [Related]
16. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.
Stremlau M; Owens CM; Perron MJ; Kiessling M; Autissier P; Sodroski J
Nature; 2004 Feb; 427(6977):848-53. PubMed ID: 14985764
[TBL] [Abstract][Full Text] [Related]
17. Cyclophilin A potentiates TRIM5α inhibition of HIV-1 nuclear import without promoting TRIM5α binding to the viral capsid.
Burse M; Shi J; Aiken C
PLoS One; 2017; 12(8):e0182298. PubMed ID: 28767697
[TBL] [Abstract][Full Text] [Related]
18. TRIM5α restriction affects clinical outcome and disease progression in simian immunodeficiency virus-infected rhesus macaques.
Wu F; Ourmanov I; Riddick N; Matsuda K; Whitted S; Plishka RJ; Buckler-White A; Starost MF; Hirsch VM
J Virol; 2015 Feb; 89(4):2233-40. PubMed ID: 25473059
[TBL] [Abstract][Full Text] [Related]
19. Caging the beast: TRIM5α binding to the HIV-1 core.
Diaz-Griffero F
Viruses; 2011 May; 3(5):423-8. PubMed ID: 21994740
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 capsids from B27/B57+ elite controllers escape Mx2 but are targeted by TRIM5α, leading to the induction of an antiviral state.
Merindol N; El-Far M; Sylla M; Masroori N; Dufour C; Li JX; Cherry P; Plourde MB; Tremblay C; Berthoux L
PLoS Pathog; 2018 Nov; 14(11):e1007398. PubMed ID: 30419009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
